News & Updates
Filter by Specialty:
Patient-reported tool helps assess symptoms, vision perception after IOL implantation
Use of the 37-item Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) instrument appears effective in evaluating symptoms and general perceptions of vision associated with cataract surgery and intraocular lens (IOL) implants, reports a study.
Patient-reported tool helps assess symptoms, vision perception after IOL implantation
05 Jul 2023
Newly diagnosed glaucoma ups risk of dementia
The risk of developing dementia, particularly Alzheimer’s disease (AD), is much higher among individuals with newly diagnosed glaucoma, suggests a study. Additionally, this association is much greater among older individuals.
Newly diagnosed glaucoma ups risk of dementia
03 Jul 2023
The unseen comorbidity of diabetes
Diabetes is the most prevalent cause of blindness in working-age individuals. However, 64 percent of Malaysians are not aware that diabetes can lead to eye problems. On the other hand, heart disease, kidney disease, and amputations are some of the health issues that come to mind when diabetes is mentioned.
The unseen comorbidity of diabetes
23 Jun 2023
OPT-302 2.0 mg plus ranibizumab leads to superior vision gains in nAMD
Treatment with 2.0-mg OPT-302, a biologic inhibitor of vascular endothelial growth factor (VEGF)-C and D, in combination with ranibizumab, an anti‒VEGF-A inhibitor, results in greater vision gains when compared with the current standard of care for neovascular age-related macular degeneration (nAMD), reports a study. In addition, the combined therapy has an acceptable safety profile.
OPT-302 2.0 mg plus ranibizumab leads to superior vision gains in nAMD
05 Jun 2023
Dietary modification ups glaucoma risk in women
Dietary modification (DM) among individuals in the lowest quartile for percentage calories from total fat at baseline is associated with a higher risk of incident primary open-angle glaucoma (POAG) among women, irrespective of age or race, suggests a recent study.
Dietary modification ups glaucoma risk in women
04 Jun 2023
Serum ADMA levels linked to circadian BP variability in glaucoma
Serum levels of asymmetric dimethylarginine (ADMA) seem to play a major role in the disturbance of circadian blood pressure (BP) variability in patients with glaucoma, suggests a recent study.
